Evidence map›Paper›PMID 38357926›Full record

ArticleThe Journal of clinical investigation2024

Reduced Bik expression drives low-grade airway inflammation and increased risk for COPD in females.

Irina Petrache, David Wh Riches

Open access · goldAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Irina PetracheDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado, USA.
David Wh RichesDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
National Jewish Health · US

Funding

Targeting early events in MUC5B-driven lung injury and fibrosisP01HL162607 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Ivana V Yang · 2023 to 2026
$12.4M
Ceramide-induced Lung Destruction in EmphysemaR01HL077328 · NHLBI · NATIONAL JEWISH HEALTH · PI PETRACHE, IRINA · 2006 to 2024
$8.0M
Fibroblast Resistance to Apoptosis in Pulmonary FibrosisR01HL140595 · NHLBI · NATIONAL JEWISH HEALTH · PI RICHES, DAVID W. · 2018 to 2021
$2.5M
Therapeutic Targeting of PTPN13 in Idiopathic Pulmonary FibrosisI01BX003471 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI RICHES, DAVID W. · 2017 to 2025
–
BLRD VA I01 BX003471Department of Defense W81XWH-21-0255NHLBI NIH HHS P01 HL162607NHLBI NIH HHS R01 HL077328NHLBI NIH HHS R01 HL140595
6 · The paper itself

Abstract

Chronic low-grade inflammation is increasingly recognized as a subtle yet potent risk factor for a multitude of age-related disorders, including respiratory diseases, cardiovascular conditions, metabolic syndromes, autoimmunity, and cancer. In this issue of the JCI, Mebratu, Jones, and colleagues shed new light on the mechanisms that promote low-grade airway inflammation and how this contributes to the development of chronic obstructive pulmonary disease (COPD). Their finding that Bik deficiency leads to spontaneous emphysema in female mice, but not in males, marks a notable advancement in our understanding of how inflammatory processes can diverge based on biological sex. This finding is of clinical relevance, given the vulnerability of women to developing COPD.

Indexed as

Pulmonary Disease, Chronic ObstructivePulmonary EmphysemaAnimalsApoptosis Regulatory ProteinsFemaleHumansInflammationMaleMiceMitochondrial ProteinsRespiratory SystemRisk FactorsApoptosis Regulatory ProteinsBik protein, mouseMitochondrial Proteins

Identifiers

PMID38357926
PMCPMC10866644
OpenAlexW4391808033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.